3/12
04:57 pm
obio
Orchestra BioMed (OBIO) had its "buy" rating reaffirmed by Chardan Capital. They now have a $20.00 price target on the stock.
Medium
Report
Orchestra BioMed (OBIO) had its "buy" rating reaffirmed by Chardan Capital. They now have a $20.00 price target on the stock.
3/12
04:31 pm
obio
Rating for OBIO
Medium
Report
Rating for OBIO